186 related articles for article (PubMed ID: 7496349)
21. Possibilities and limitations of cytochemical methods in diagnosis of acute leukemia.
Klobusická M
Micron; 1994; 25(4):317-29. PubMed ID: 7987625
[TBL] [Abstract][Full Text] [Related]
22. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
23. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
24. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
25. Detection of myeloperoxidase by flow cytometry in acute leukemia.
Nakase K; Sartor M; Bradstock
Cytometry; 1998 Aug; 34(4):198-202. PubMed ID: 9725460
[TBL] [Abstract][Full Text] [Related]
26. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
27. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
28. Myeloid lineage specificity and high sensitivity of monoclonal antibody GM 58/8 proves its usefulness as a diagnostic reagent in acute leukemia.
Das Gupta A; Dhond SR; Barbhaya SA; Advani SH
Am J Hematol; 1987 Jun; 25(2):125-30. PubMed ID: 3300282
[TBL] [Abstract][Full Text] [Related]
29. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
30. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
31. Surface markers in acute non-lymphoid leukemia: analysis with a panel of 36 monoclonal antibodies.
Campos L; Guyotat D; Gentilhomme O; Treille D; Archimbaud E; Fiere D; Germain D
Blut; 1987 Feb; 54(2):65-71. PubMed ID: 3814828
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India.
Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN
Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279
[TBL] [Abstract][Full Text] [Related]
33. [Immunophenotypic analysis in acute leukemia].
Akashi K; Harada M
Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.
Saussoy P; Vaerman JL; Straetmans N; Deneys V; Cornu G; Ferrant A; Latinne D
Clin Chem; 2004 Jul; 50(7):1165-73. PubMed ID: 15229149
[TBL] [Abstract][Full Text] [Related]
35. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.
Macedo A; San Miguel JF; Vidriales MB; López-Berges MC; García-Marcos MA; Gonzalez M; Landolfi C; Orfão A
J Clin Pathol; 1996 Jan; 49(1):15-8. PubMed ID: 8666678
[TBL] [Abstract][Full Text] [Related]
37. [Detection of cytoplasmic antigens by flow cytometry and its implication for leukemia immunophenotyping].
Liu YR; Yu H; Chang Y; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):17-21. PubMed ID: 12513830
[TBL] [Abstract][Full Text] [Related]
38. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
39. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
Bene MC; Castoldi G; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer MB
Leukemia; 1995 Oct; 9(10):1783-6. PubMed ID: 7564526
[TBL] [Abstract][Full Text] [Related]
40. Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell lines.
Toba K; Hanawa H; Sakaue M; Yoshida K; Itoh H; Tsuchiyama J; Maruyama S; Narita M; Takahashi M; Watanabe K; Aizawa Y
Leuk Res; 2003 Feb; 27(2):173-82. PubMed ID: 12526923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
